Project Grant HT94252510216

Award Date 5/15/25
Completion Date 5/14/29
Dollars Obligated $2.4M
Federal Grant Program
12.420
Assistance Type
Project Grant
Place of Performance
Baltimore, MD 21218, USA
Similar Awards
The Department of the Army Medical Command awarded a $319,938 project grant under the Military Medical Research and Development (CFDA 12.420) program to The Johns Hopkins University. The grant, with a performance period from September 1, 2024 to August 31, 2026, will fund a large-scale MRI-based study to determine multiple sclerosis-specific atrophy phenotypes. This research aims to transform healthcare for military service members and the broader public by advancing the understanding and...
This Project Grant award from the Department of the Army Medical Command under the Military Medical Research and Development program (CFDA 12.420) provides $855,728 to The Johns Hopkins University to identify abnormally regulated lipid pathways in human motor neuron and fly models, with the goal of developing a new pharmacological drug candidate. The award period runs from Sep 1, 2024 to Aug 31, 2026. As a leading research university, Johns Hopkins has a strong track record of federal grant...
The Johns Hopkins University will provide research services under a $724,845 Project Grant from the Defense Health Agency's Military Medical Research and Development program. Specifically, Johns Hopkins will conduct applied biomedical studies from June 2023 through May 2026 to regenerate chronically denervated muscle through development of an injectable myoblast scaffold. The Military Medical Research and Development program aims to transform military and public health through innovative...
The Johns Hopkins University was awarded a $647,632 Project Grant from the Defense Health Agency under the Military Medical Research and Development program. The grant will fund a research project from August 1, 2023 to July 31, 2026 to leverage a precision medicine platform to predict novel therapies for malignant peripheral nerve sheath tumors. Through the support of basic, applied, and advanced biomedical research, the Military Medical Research and Development program aims to transform health...
The Johns Hopkins University was awarded a $806,712 Project Grant from the Department of the Army Medical Command under the Military Medical Research and Development program (CFDA 12.420). The grant will fund research from September 2022 through September 2025 to investigate exosomal activity in military personnel and its relationship to perivascular space and sleep metrics indicators. Through this research, the University aims to advance understanding of medical solutions for battlefield...
The Johns Hopkins University has been awarded a $1,099,238 Project Grant under the Department of Defense's Military Medical Research and Development program (CFDA 12.420) with a period of performance from September 1, 2024 to August 31, 2026. This grant will support investigator-initiated biomedical research projects across multiple medical disciplines to improve health outcomes for military service members, veterans, and the broader public. The award enables Johns Hopkins to conduct...
The Johns Hopkins University was awarded a $974,999.00 Project Grant by the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420). The three-year grant, spanning August 1, 2023 to July 31, 2026, will support research to engineer an effective combination therapy of car T cells and regulatory T cells to control rejection of vascularized composite allografts. This research aims to develop medical solutions for the battlefield and transform healthcare for...
The Johns Hopkins University was awarded an $849,818 project grant from the Department of the Army Medical Command under the Military Medical Research and Development program (CFDA 12.420). The grant will support research from September 2022 through September 2025 to engineer thymic selection to control the development of alloreactive T cells and promote vascularized composite allograft acceptance. The Military Medical Research and Development program aims to transform military and public health...
The Johns Hopkins University will receive $966,758 under a Project Grant award from the Department of the Army Medical Command. The grant is part of the Military Medical Research and Development program administered under Assistance Listing Number 12.420. Under this three-year award ending in August 2025, The Johns Hopkins University will investigate circulating central nervous system cell-derived extracellular vesicle based biomarkers to identify neurodegeneration and glial activation in...
This federal Project Grant award from the Department of the Army Medical Command under the Military Medical Research and Development program (CFDA 12.420) provides $2,046,849.00 to The Johns Hopkins University to conduct research on the expression of muscle glutamate carboxypeptidase II as a biomarker for lower motor neuron involvement in spinal cord injury and as a target for PET imaging. The award period runs from December 1, 2024 to November 30, 2027. As a leading academic research...

The U.S. Department of the Army Medical Command awarded a $2,382,063 Project Grant to The Johns Hopkins University under the Military Medical Research and Development (CFDA 12.420) federal grant program. The grant, titled "NERVE TO HEAL: OPTIMIZATION OF TENDON HEALTH USING NERVE-SPECIFIC SMALL MOLECULES," supports advanced biomedical research focused on transforming healthcare for military service members and the broader public. The research aims to investigate innovative approaches to disease prevention, diagnosis, treatment, and management, with a particular emphasis on conditions relevant to military personnel and veterans. The project will be conducted at The Johns Hopkins University in Baltimore, Maryland over a 4-year period from May 2025 to May 2029.

Generated 6/17/25, 5:36 AM